IP Library Granted Patent US 7,884,141
Granted Patent B2
US 7,884,141 · App. 12/248,202 · Granted Feb 8, 2011

Biomedical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,884,141
App. No.
12/248,202
Granted
Feb 8, 2011
Kind
B2
Abstract

Biomedical devices are provided herein which are formed from a polymerization product of a monomeric mixture comprising (a) one or more esterified aminoalcohol monomers; and (b) one or more biomedical device-forming monomers.

Claims (14)

1. A hydrogel contact lens formed from a polymerization product of a monomeric mixture comprising (a) one or more esterified aminoalcohol monomers of the general Formula I:

wherein X is a polymerizable ethylenically unsaturated organic ester-containing radical, R 1 is hydrogen, or a C 1 -C 30 non-polymerizable hydrocarbyl group optionally substituted with a hydroxyl group, and R 2 is a hydroxyl-containing non-polymerizable group; and (b) one or more lens forming comonomers.

2. The contact lens of claim 1 , wherein X is a vinyl ester-containing radical.

3. The contact lens of claim 1 , wherein X is a (meth)acrylate ester-containing radical.

4. The contact lens of claim 1 , wherein R 2 is a hydroxyl substituted C 1 -C 6 alkyl group.

5. The contact lens of claim 1 , wherein R 1 is an alcohol of the general formula —R 3 OH wherein R 3 is a straight or branched C 1 -C 30 alkyl group and R 2 is a hydroxyl substituted C 1 -C 6 alkyl group.

6. The contact lens of claim 1 , wherein the esterified aminoalcohol monomer is represented by the structure of general Formula II:

wherein X and R 1 have the aforestated meanings and R 2 is a straight or branched C 1 -C 6 alkyl group, and the lens-forming comonomer is a silicone-containing monomer.

7. The contact lens of claim 6 , wherein R 1 is an alcohol of the general formula —R 7 OH wherein R 7 is a straight or branched C 1 -C 6 alkyl group and R 2 is a C 1 -C 6 alkyl group.

8. The contact lens of claim 1 , wherein the lens-forming comonomer is a silicone-containing monomer.

9. The contact lens of claim 1 , wherein the monomeric mixture further comprises a hydrophilic monomer.

10. The contact lens of claim 9 , wherein the hydrophilic monomer includes an acrylic-containing monomer.

11. The contact lens of claim 9 , wherein the hydrophilic monomer includes a vinyl-containing monomer.

12. The contact lens of claim 9 , wherein the hydrophilic monomer includes at least one member selected from the group consisting of N,N-dimethylacrylamide and N-vinylpyrrolidone.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Mar 21, 2011
From: WP PRISM INC.; BAUSCH & LOMB INCORPORATED
To: CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT
Reel/Frame 025990/0222 →